Antiaging Quantum Living Inc.
AAQL
$0.58
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 150.55% | -95.66% | 120.26% | 125.29% | 44.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 150.55% | -95.66% | 120.26% | 125.29% | 44.19% |
| Cost of Revenue | 635.80% | -80.12% | 2,523.08% | 356.25% | 28,250.00% |
| Gross Profit | 33.32% | 25.15% | 36.57% | 104.35% | 16.25% |
| SG&A Expenses | 70.56% | 219.41% | 36.80% | 5.36% | -10.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 145.16% | -17.41% | 73.37% | 19.01% | 3.27% |
| Operating Income | -133.79% | -108.31% | -36.92% | 74.12% | 35.39% |
| Income Before Tax | -150.00% | -106.18% | -110.60% | 74.10% | 40.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -138.76% | -106.29% | -110.68% | 68.84% | 37.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -138.76% | -106.29% | -110.68% | 68.84% | 37.63% |
| EBIT | -133.79% | -108.31% | -36.92% | 74.12% | 35.39% |
| EBITDA | -205.47% | -152.86% | -40.41% | 95.08% | 47.08% |
| EPS Basic | -111.36% | -80.00% | -100.00% | 68.18% | 38.03% |
| Normalized Basic EPS | -114.81% | -83.78% | -100.00% | 73.17% | 40.00% |
| EPS Diluted | -111.36% | -80.00% | -100.00% | 68.18% | 38.03% |
| Normalized Diluted EPS | -114.81% | -83.78% | -100.00% | 73.17% | 40.00% |
| Average Basic Shares Outstanding | 14.27% | 14.10% | 5.74% | 0.15% | 0.00% |
| Average Diluted Shares Outstanding | 14.27% | 14.10% | 5.74% | 0.15% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |